Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7181-7196
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7181
Table 3 Hepatitis B virus genotypes, clinical and serological characteristics and type of liver damage in Mexico and Central America n (%)
Ref.CountryStudy populationnHBsAg
Anti-HBc
HBV genotypes1
Diagnosis
PositiveABCDEFGH
Sanchez et al[107], 2002MexicoHBV-infected adults1513 (87)6 (40)3 (20)--1 (7)-10 (67)1 (7)-AH in 30%;
CH in 27%;
cirrhosis in 7%.
Sanchez et al[50], 2007HBV-infected patients6767 (100)NA10 (15)--4 (6)4 (6)44 (66)AH in 15%;
CH in 48%
Ruiz-Tachiquin et al[151], 2007Blood donors and HBV-infected patients3333 (100)NA--4 (12)1 (3)-26 (79)Asymp in 64%; CH in 36%
Roman et al[98], 2010Native adults30617 (5.6)100 (32.7)6 (24)1 (4)2 (8)4 (16)-1 (4)11 (44)OHB in 14.2%; asymp in 100%
Arauz-Ruiz et al[115], 1997Central America:HBV-infected patients, blood donors and pregnant woman330330 (100)71 (21)13 (14)-1 (1)5 (6)71 (79)-CH in 21%;
Costa Rica, Nicaragua,F1a; F1b; F2AH in 16%
Honduras, El Salvador, Guatemala
Leon et al[122], 2005Costa RicaHBV-infected patients5032 (64)18 (36)---2 (4)-48 (96)-CH in 47%;
HCC in 16%
Kato et al[123], 2005PanamaHBV-infected patients2NANA----2 (100)--NA
F1, F3
Martinez et al[124], 2013Chinese residents32042 (13)-11 (61)7 (39)-----No evident liver disease
B2C1
Andernach et al[125], 2009HaitíPregnant woman320320 (100)128 (71)--40 (22)11 (6)---NA
A1, A2, A5D3, D4
Couto et al[126], 2013Haitian’s in South Florida27NANA---19 (79)----NA